期刊文献+

肾上腺髓质素2在重要脏器的生物学效应

Biological effect of adrenomedullin 2 on important organs
下载PDF
导出
摘要 肾上腺髓质素2是近年来新发现的一种小分子活性肽,其作为心血管、肾脏、肺脏等重要脏器的内源性保护因子,参与机体内环境稳态的调节,具有降低血压、抗动脉粥样硬化、抗纤维化、抗凋亡、保护器官缺血再灌注损伤、调控血管生成等作用,在多种脏器和系统的病理生理过程中发挥着多样而强大的生物学效应。本文将对肾上腺髓质素2的生物学特性、组织分布、受体结合及其在心肺肾等重要脏器发挥的生物学效应进行总结,以加深对肾上腺髓质素2生物学作用机制的了解和认识。
作者 谢静 曾强
出处 《解放军医学院学报》 CAS 2013年第6期654-658,共5页 Academic Journal of Chinese PLA Medical School
基金 国家科技支撑计划(2012BAI37B04)~~
  • 相关文献

参考文献1

二级参考文献27

  • 1Creemers EE and Pinto YM. Molecular mechanisms that control interstitial fibrosis in the pressure-overloaded heart. Cardiovasc Res 2011, 89: 265 272.
  • 2Chang CL, Roh J and Hsu SY. Intermedin, a novel calcitonin family peptide that exists in teleosts as well as in mammals: a comparison with other calcitonin/intermedin family peptides in vertebrates. Peptides 2004, 25: 1633-1642.
  • 3Roh J, Chang CL, Bhalla A, Klein C and Hsu SY. Intermedin is a calci- tonin/calcitonin gene-related peptide family peptide acting through the cal- citonin receptor-like receptor/receptor activity-modifying protein receptor complexes. J Biol Chem 2004, 279: 7264-7274.
  • 4Cottrell GS, Alemi F, Kirkland JG, Grady EF, Corvera CU and Bhargava A. Localization of calcitonin receptor-like receptor (CLR) and receptor activity-modifying protein l (RAMP1) in human gastrointestinal tract. Peptides 2012, 35:202-211.
  • 5Pfeil U, Aslam M, Paddenberg R, Quanz K, Chang CL, Park JI and Gries B, et al. Intermedin/adrenomedullin-2 is a hypoxia-induced endothelial peptide that stabilizes pulmonary microvascular permeability. Am J Physiol Lung Cell Mol Physiol 2009, 297: L837-L845.
  • 6Egbert B, Gem T, Paul B, Burkhard S, Sebastian B, von Dirk L and Burkert P. Atrial myocardium is the predominant inotropic target of adre- nomedullin in the human heart. Am J Physiol Heart Circ Physiol 2007, 293: H3001-H3007.
  • 7Zeng Q, Yuan Y, Wang X, Wu HM, Fan L, Qi YF and Tang CS, et al. Upregulated expression of intermedin and its receptor in the myocardium and aorta in spontaneously hypertensive rots. Peptides 2009, 30:391 399.
  • 8Hay DL, Conner AC, Howitt SG, Smith DM and Poyner DR. The pharma- cology of adrenomedullin receptors and their relationship to CGRP recep- tors. J Mol Neurosci 2004, 22:105 113.
  • 9Pan CS, Yang JH, Cai DY, Zhao J, Gems H, Yang J and Chang JK, et al. Cardiovascular effects of newly discovered peptide intermedin/adrenome- dullin 2. Peptides 2005, 26: 1640-1646.
  • 10Hagiwara M, Bledsoe G, Yang ZR, Smith RS Jr, Chao L and Chao J. Intermedin ameliorates vascular and renal injury by inhibition of oxidative stress. Am J Physiol Renal Physiol 2008, 295: F1735-FI743.

共引文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部